Fuchs E, Weber K. Intermediate filaments: structure, dynamics, functions, and disease. Ann Rev Biochem 1994, 63: 345 - 382.
Fuchs E. The cytoskeleton and disease: genetic disorders of intermediate filaments. Ann Rev Genet 1996, 30: 197 - 231.
Guevara ME, Mota D, Grases PJ, García Tamayo J. Tumores fusocelulares de difícil diagnóstico: estudio histológico y ultraestructural. Morfol Norm y Patol. Secc B (Esp) 1980, 4:533 - 548.
García Tamayo J, Fraiz Grijalba T, Oviedo de Ayala N, Pinto JA. Tumores de músculo liso estudio clínico, histológico y ultraestructural. Patología (Mex) 1980, 18: 221 - 238.
García Tamayo J. Aspectos ultraestructurales de la patología tumoral. Invest Clin 1982, 3: 123 - 215.
García Tamayo J. Ultraestructura e inmunohistoquímica como ayuda diagnóstica en Anatomía Patológica. Rev Ven de Oncología 1991, 3: 1 - 7.
Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: pattern of expression in normal epithelia, tumor and culture cells. Cell 1982, 31: 11 - 24.
Sun TT, Skelton HG, Green H. Keratin cytoskeletons in epithelial cells of internal organs. Proc Nat Acad Sci USA 1979, 76: 2813 - 2817.
Miettinen M. Keratin immunohistochemistry: update on applications and pitfalls. Pathol Annu 1993, 8: 113 -143.
Ramaekers FC, Huysmans A, Moesker O y col. Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumors. Lab Invest 1983, 49: 353 - 361.
Nagle RB, McDaniel KM, Clark VA, Payne CM. The use of antikeratin antibodies in the diagnosis of human neoplasms. Am J Clin Pathol 1983, 79: 458 - 466.
Bartex J, Vojtesek B, Staskova Z, Bartkova J, Kerekes Z, Rejthar A. A series of 14 new monoclonal antibodies to keratins: characterization and value in diagnostic histopathology. J Pathol 1991, 164: 215 - 224.
Berezoswski K, Stastny JF, Kornstein MJ. Cytoketains 7 and and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Mod Pathol 1995, 9: 426 - 429.
Maeda T, Kajiyama K, Adachi E, Takenaka K, Sugimachi K, Tsuneyoshi M. The expression of cytokeratins 7, 19, 20 in primary and metastatic carcinomas of the liver. Mod Pathol 1996, 9: 901 - 909.
Chu PG, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000, 13: 962 - 972.
Osborn M, Weber K. Tumor diagnosis by intermediate filamente typing: a novel tool or surgical pathology. Lab Invest 1983, 48: 372 - 394.
Gown AM, Vogel AM. Monocolnal antibodies to human intermediate filament proteins. Am J Clin Pathol 1985, 84: 413 - 424.
Schlegel R, Bank-Schlegel S, McLeod JA, Pinkus G. Immunoperoxidase localization of keratin in human neoplasms. Am J Pathol 1980, 101: 41 - 50.
Steinert PM, Roop DR. Molecular and cellular biology of intermediate filaments. Ann Rev Biochem 1988, 577, 593 - 625.
Moll R, Zimbelmann R, Goldschmitd MD y col. The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas. Differentiation 1993, 53: 75 - 93.
Chu PG, Lyda MH, Weiss LM. Cytokeratin 14 expression in epithelial neoplasms: a survey of 453 cases with emphasis on its value in differentiating squamous cell carcinomas from other epithelial tumours. Histopathology 2001 39: 9 -16.
Chu PG, Weiss LM. Expression of Cytokeratin 5/6 in epithelial neoplasias.: an immunohistochemical study of 509 cases. Mod Pathol 2002, 15: 6 - 10.
Wang NP, Zae S, Zarbo RJ, Bacchi CE, Gown AM. Coordinate exprtession of cytokeratin 7 and 20 define unique subsets of carcinomas. Appl Immunohistochem 1995, 3: 99 - 107.
Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology 2002, 40: 403 - 439.
Srigley JR, Eble JN. Collecting duct carcinoma of the kidney. Sem Diag Pathol 1998, 115: 54 - 67.
García Tamayo J, Hernández C. Algunas consideraciones sobre la inmunohistoquímica en el diagnóstico diferencial entre Mesotelioma y Adenocarcinoma.Vitae Academia Biomédica Digital, Vol 13, 2002.http://caibco.ucv.ve/Vitae/VitaeTrece/Articulos/AnatomiaPatologica/ ArchivosHTML/Introduccion.htm
Ordóñez N. Value of cytokeratin 5/6 in distinguishing epitehlial mesothelioma of the pleura from adenocarcinoma. Am J Surg Pathol 1998, 22: 1215 - 1221.
Moll R, Lowe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992, 140: 427 - 447.
McKenney JK, Desai S, Cohen C, Amin MB. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53 and CD44 antigens. Am J Surg Pathol 2001, 25: 1074 - 1078.
Blasco-Olaetxea E, Belloso IK, García Tamayo J. Superficial Bladder Cancer. Study of the Proliferative Nuclear Fraction as a Prognostic Factor. Europ J Cancer 1996, 32: 444 - 446.
Basssily NH, Vallorsi CJ, Akdlas G, Montie JE, Robin MA. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma. Am J Clin Pathol 2000, 113: 383 - 388.
Branner MK, Peehl DM, Stamey TA, Bostwick DC. Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res 1985, 45: 3663 - 3367.
Smedts F, Ramarkers FC, Vooijs P. The dinamics of keratin expression in malignant transformation of cervical epithelium: a review. Obs. Gynecol. 1993, 82: 465 - 474.
Harnden P, Southgate J. Cytokeratin 14 as a marker of squamous differentiation in transitional cell carcinomas. J Clin Pathol 1997, 50: 1032-1033
Heatley MK. Cytokeratin 10/13, 14, 7, 8 and 18 in invasive squamous cell carcinoma and adenocarcinoma of the uterine cervix. J Clin Pathol 1999, 52: 789.
Krane JF, O´Connel JT, Pilch BZ, Faquin WC. Cytokeratin and mucin expression in intestinal type sinonasal adenocarcinomas (abstract). Mod Pathol 2000, 70: 410 - 413.
Adem C, Reynolds H, Adlakha H, Roche PC, Nascimento AG. Wide spectrum screening keratin as a marker of metaplastic spindle cell carcinoma of the breast: an immunohistochemical study od 24 patients. Histopathology 2002, 40: 556 - 562.
Chu PG, Weiss LM. Cytokeratin 14 expression distinguishes oncocytic tumor from its congeners: an immunohistochemical study of 31 cases. Histopathology 2001, 39: 9 -16.
Prasad ML, Hyjek E, Giri DD, Ying L, O´leary JJ, Hoda SA. Double immunolabelling with cytokeratin and smooth muscle actin in confirming early invasive carcinoma of the breast. Am J Surg Pathol 1999, 23: 176-181.
Loose JH, Patchefsky AS, Hollander IJ, Lavin LS, Coopewr HS, Katz SM. Adenomyopeitleioma of the breast. A spectrum of biological behavior. Am J Surg Pathol 1992, 16: 868-876.
Wetzels RH, Kuijpers HJ, Lane EB y col. Basal cell specific and hyperproliferation-related keratins in human breast cancer. Am J Pathol 1991, 138: 751-763.
Baloch ZM, Abraham S Roberts S, Livosli V. Differential expression of cytokeratin in follicular variant of papillary carcinoma: an immunohistochemical study and its diagnostic utility. Huma Pathol 1999, 30: 1166 - 1171.
NOTA:Toda la información que se brinda en este artículo es de carácter investigativo y con fines académicos y de actualización para estudiantes y profesionales de la salud. En ningún caso es de carácter general ni sustituye el asesoramiento de un médico. Ante cualquier duda que pueda tener sobre su estado de salud, consulte con su médico o especialista.
Instituto de Medicina Tropical - Facultad de Medicina - Universidad Central de Venezuela.
Elaborado por el Centro de Análisis de Imágenes Biomédicas Computarizadas CAIBCO, caibco@ucv.ve
Este portal ha sido desarrollado gracias al apoyo del Fonacit
